0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Imbruvica Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-4C2438
Home | Market Reports | Health| Nursing
Global Imbruvica Market Insights and Forecast to 2028
BUY CHAPTERS

Global Imbruvica Market Research Report 2024

Code: QYRE-Auto-4C2438
Report
January 2024
Pages:61
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Imbruvica Market

Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.
The global Imbruvica market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Imbruvica is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Imbruvica is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Imbruvica in Mantle Cell Lymphoma is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Imbruvica include AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech) and SP Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Imbruvica, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Imbruvica.

Report Scope

The Imbruvica market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Imbruvica market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Imbruvica companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Imbruvica Market Report

Report Metric Details
Report Name Imbruvica Market
Segment by Type
  • 5 mg
  • 10 mg
  • 140 mg
Segment by Application
  • Mantle Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Waldenström's Macroglobulinemia
  • Relapsed/Refractory Marginal Zone Lymphoma
  • Chronic Graft-Versus-Host-Disease
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech), SP Laboratories
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Imbruvica companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Imbruvica Market report?

Ans: The main players in the Imbruvica Market are AbbVie (Pharmacyclics), Johnson & Johnson (Janssen Biotech), SP Laboratories

What are the Application segmentation covered in the Imbruvica Market report?

Ans: The Applications covered in the Imbruvica Market report are Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, Waldenström's Macroglobulinemia, Relapsed/Refractory Marginal Zone Lymphoma, Chronic Graft-Versus-Host-Disease

What are the Type segmentation covered in the Imbruvica Market report?

Ans: The Types covered in the Imbruvica Market report are 5 mg, 10 mg, 140 mg

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imbruvica Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 5 mg
1.2.3 10 mg
1.2.4 140 mg
1.3 Market by Application
1.3.1 Global Imbruvica Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Mantle Cell Lymphoma
1.3.3 Chronic Lymphocytic Leukemia
1.3.4 Waldenström's Macroglobulinemia
1.3.5 Relapsed/Refractory Marginal Zone Lymphoma
1.3.6 Chronic Graft-Versus-Host-Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imbruvica Market Perspective (2019-2030)
2.2 Imbruvica Growth Trends by Region
2.2.1 Global Imbruvica Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Imbruvica Historic Market Size by Region (2019-2024)
2.2.3 Imbruvica Forecasted Market Size by Region (2025-2030)
2.3 Imbruvica Market Dynamics
2.3.1 Imbruvica Industry Trends
2.3.2 Imbruvica Market Drivers
2.3.3 Imbruvica Market Challenges
2.3.4 Imbruvica Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imbruvica Players by Revenue
3.1.1 Global Top Imbruvica Players by Revenue (2019-2024)
3.1.2 Global Imbruvica Revenue Market Share by Players (2019-2024)
3.2 Global Imbruvica Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imbruvica Revenue
3.4 Global Imbruvica Market Concentration Ratio
3.4.1 Global Imbruvica Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imbruvica Revenue in 2023
3.5 Imbruvica Key Players Head office and Area Served
3.6 Key Players Imbruvica Product Solution and Service
3.7 Date of Enter into Imbruvica Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imbruvica Breakdown Data by Type
4.1 Global Imbruvica Historic Market Size by Type (2019-2024)
4.2 Global Imbruvica Forecasted Market Size by Type (2025-2030)
5 Imbruvica Breakdown Data by Application
5.1 Global Imbruvica Historic Market Size by Application (2019-2024)
5.2 Global Imbruvica Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Imbruvica Market Size (2019-2030)
6.2 North America Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Imbruvica Market Size by Country (2019-2024)
6.4 North America Imbruvica Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Imbruvica Market Size (2019-2030)
7.2 Europe Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Imbruvica Market Size by Country (2019-2024)
7.4 Europe Imbruvica Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imbruvica Market Size (2019-2030)
8.2 Asia-Pacific Imbruvica Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Imbruvica Market Size by Region (2019-2024)
8.4 Asia-Pacific Imbruvica Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Imbruvica Market Size (2019-2030)
9.2 Latin America Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Imbruvica Market Size by Country (2019-2024)
9.4 Latin America Imbruvica Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imbruvica Market Size (2019-2030)
10.2 Middle East & Africa Imbruvica Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Imbruvica Market Size by Country (2019-2024)
10.4 Middle East & Africa Imbruvica Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie (Pharmacyclics)
11.1.1 AbbVie (Pharmacyclics) Company Detail
11.1.2 AbbVie (Pharmacyclics) Business Overview
11.1.3 AbbVie (Pharmacyclics) Imbruvica Introduction
11.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2019-2024)
11.1.5 AbbVie (Pharmacyclics) Recent Development
11.2 Johnson & Johnson (Janssen Biotech)
11.2.1 Johnson & Johnson (Janssen Biotech) Company Detail
11.2.2 Johnson & Johnson (Janssen Biotech) Business Overview
11.2.3 Johnson & Johnson (Janssen Biotech) Imbruvica Introduction
11.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2019-2024)
11.2.5 Johnson & Johnson (Janssen Biotech) Recent Development
11.3 SP Laboratories
11.3.1 SP Laboratories Company Detail
11.3.2 SP Laboratories Business Overview
11.3.3 SP Laboratories Imbruvica Introduction
11.3.4 SP Laboratories Revenue in Imbruvica Business (2019-2024)
11.3.5 SP Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Imbruvica Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of 5 mg
    Table 3. Key Players of 10 mg
    Table 4. Key Players of 140 mg
    Table 5. Global Imbruvica Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Imbruvica Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Imbruvica Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Imbruvica Market Share by Region (2019-2024)
    Table 9. Global Imbruvica Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Imbruvica Market Share by Region (2025-2030)
    Table 11. Imbruvica Market Trends
    Table 12. Imbruvica Market Drivers
    Table 13. Imbruvica Market Challenges
    Table 14. Imbruvica Market Restraints
    Table 15. Global Imbruvica Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Imbruvica Market Share by Players (2019-2024)
    Table 17. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imbruvica as of 2023)
    Table 18. Ranking of Global Top Imbruvica Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by Imbruvica Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Imbruvica Product Solution and Service
    Table 22. Date of Enter into Imbruvica Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Imbruvica Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Imbruvica Revenue Market Share by Type (2019-2024)
    Table 26. Global Imbruvica Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Imbruvica Revenue Market Share by Type (2025-2030)
    Table 28. Global Imbruvica Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Imbruvica Revenue Market Share by Application (2019-2024)
    Table 30. Global Imbruvica Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Imbruvica Revenue Market Share by Application (2025-2030)
    Table 32. North America Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America Imbruvica Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America Imbruvica Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe Imbruvica Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe Imbruvica Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific Imbruvica Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific Imbruvica Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific Imbruvica Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America Imbruvica Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America Imbruvica Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa Imbruvica Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa Imbruvica Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa Imbruvica Market Size by Country (2025-2030) & (US$ Million)
    Table 47. AbbVie (Pharmacyclics) Company Detail
    Table 48. AbbVie (Pharmacyclics) Business Overview
    Table 49. AbbVie (Pharmacyclics) Imbruvica Product
    Table 50. AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2019-2024) & (US$ Million)
    Table 51. AbbVie (Pharmacyclics) Recent Development
    Table 52. Johnson & Johnson (Janssen Biotech) Company Detail
    Table 53. Johnson & Johnson (Janssen Biotech) Business Overview
    Table 54. Johnson & Johnson (Janssen Biotech) Imbruvica Product
    Table 55. Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2019-2024) & (US$ Million)
    Table 56. Johnson & Johnson (Janssen Biotech) Recent Development
    Table 57. SP Laboratories Company Detail
    Table 58. SP Laboratories Business Overview
    Table 59. SP Laboratories Imbruvica Product
    Table 60. SP Laboratories Revenue in Imbruvica Business (2019-2024) & (US$ Million)
    Table 61. SP Laboratories Recent Development
    Table 62. Research Programs/Design for This Report
    Table 63. Key Data Information from Secondary Sources
    Table 64. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Imbruvica Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Imbruvica Market Share by Type: 2023 VS 2030
    Figure 3. 5 mg Features
    Figure 4. 10 mg Features
    Figure 5. 140 mg Features
    Figure 6. Global Imbruvica Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Imbruvica Market Share by Application: 2023 VS 2030
    Figure 8. Mantle Cell Lymphoma Case Studies
    Figure 9. Chronic Lymphocytic Leukemia Case Studies
    Figure 10. Waldenström's Macroglobulinemia Case Studies
    Figure 11. Relapsed/Refractory Marginal Zone Lymphoma Case Studies
    Figure 12. Chronic Graft-Versus-Host-Disease Case Studies
    Figure 13. Imbruvica Report Years Considered
    Figure 14. Global Imbruvica Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Imbruvica Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Imbruvica Market Share by Region: 2023 VS 2030
    Figure 17. Global Imbruvica Market Share by Players in 2023
    Figure 18. Global Top Imbruvica Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imbruvica as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Imbruvica Revenue in 2023
    Figure 20. North America Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Imbruvica Market Share by Country (2019-2030)
    Figure 22. United States Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Imbruvica Market Share by Country (2019-2030)
    Figure 26. Germany Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Imbruvica Market Share by Region (2019-2030)
    Figure 34. China Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Imbruvica Market Share by Country (2019-2030)
    Figure 42. Mexico Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Imbruvica Market Share by Country (2019-2030)
    Figure 46. Turkey Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Imbruvica Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. AbbVie (Pharmacyclics) Revenue Growth Rate in Imbruvica Business (2019-2024)
    Figure 49. Johnson & Johnson (Janssen Biotech) Revenue Growth Rate in Imbruvica Business (2019-2024)
    Figure 50. SP Laboratories Revenue Growth Rate in Imbruvica Business (2019-2024)
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS